110 related articles for article (PubMed ID: 21195543)
1. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells.
Lepage C; Léger DY; Bertrand J; Martin F; Beneytout JL; Liagre B
Cancer Lett; 2011 Feb; 301(2):193-202. PubMed ID: 21195543
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding.
Liagre B; Bertrand J; Leger DY; Beneytout JL
Int J Mol Med; 2005 Dec; 16(6):1095-101. PubMed ID: 16273292
[TBL] [Abstract][Full Text] [Related]
3. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.
Woo JS; Kim SM; Jeong CH; Ryu CH; Jeun SS
Biochem Biophys Res Commun; 2013 Feb; 431(2):354-9. PubMed ID: 23261452
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells.
Abdollahi T; Robertson NM; Abdollahi A; Litwack G
Apoptosis; 2005 Dec; 10(6):1383-93. PubMed ID: 16215677
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis.
Kim SL; Liu YC; Park YR; Seo SY; Kim SH; Kim IH; Lee SO; Lee ST; Kim DG; Kim SW
Int J Oncol; 2015 Mar; 46(3):1121-30. PubMed ID: 25502339
[TBL] [Abstract][Full Text] [Related]
8. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
Cancer Lett; 2010 Jan; 287(1):98-108. PubMed ID: 19577358
[TBL] [Abstract][Full Text] [Related]
9. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells.
Lamy V; Bousserouel S; Gossé F; Minker C; Lobstein A; Raul F
Oncol Rep; 2011 Jul; 26(1):109-14. PubMed ID: 21519792
[TBL] [Abstract][Full Text] [Related]
10. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
[TBL] [Abstract][Full Text] [Related]
11. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.
Shenoy K; Wu Y; Pervaiz S
Cancer Res; 2009 Mar; 69(5):1941-50. PubMed ID: 19223550
[TBL] [Abstract][Full Text] [Related]
12. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
Kim EY; Ryu JH; Kim AK
Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
14. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Jayasooriya RG; Choi YH; Hyun JW; Kim GY
Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
[TBL] [Abstract][Full Text] [Related]
17. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
18. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
19. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
20. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
